Metabolic Messengers: ceramides | Nature Metabolism
SMPDL3b regulates the insulin-signaling pathway in human podocytes. a... | Download Scientific Diagram
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
A review of the molecular pathways mediating the improvement in diabetes mellitus following caloric restriction - Yaribeygi - 2019 - Journal of Cellular Physiology - Wiley Online Library
Role of ceramides in the pathogenesis of diabetes mellitus and its complications - ScienceDirect
Frontiers | The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines | Endocrinology
The role of ceramides in metabolic disorders: when size and localization matters | Nature Reviews Endocrinology
The role of sphingosine‐1‐phosphate in skeletal muscle: Physiology, mechanisms, and clinical perspectives - Cordeiro - 2019 - Journal of Cellular Physiology - Wiley Online Library
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science
Defining lipid mediators of insulin resistance: controversies and challenges in: Journal of Molecular Endocrinology Volume 62 Issue 1 (2019)
ceramide hashtag on Twitter
Role of ceramides in the pathogenesis of diabetes mellitus and its complications - ScienceDirect
Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
Reassessing the Role of Diacylglycerols in Insulin Resistance: Trends in Endocrinology & Metabolism
ceramide hashtag on Twitter
Frontiers | Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet | Physiology
JLA :: Journal of Lipid and Atherosclerosis
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications
Podocyte lipotoxicity in diabetic kidney disease - Kidney International
Frontiers | Ceramides in Adipose Tissue | Endocrinology
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications
PDF) Interplay between ceramides and phytonutrients: New insights in metabolic syndrome
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. - Abstract - Europe PMC
Insulin signaling requires glucose to promote lipid anabolism in adipocytes - Journal of Biological Chemistry
